Related Experiment Video
Updated: Jul 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Restenosis after percutaneous angioplasty: the role of vascular inflammation
Martin Schillinger1, Erich Minar
1Department of Angiology, University of Vienna Medical School, Vienna, Austria. martin.schillinger@meduniwien.ac.at
Insights
Restenosis, a complication of endovascular treatments, is often driven by vascular inflammation. Identifying inflammatory markers can predict restenosis risk, improving outcomes after angioplasty, especially in peripheral arteries.
Area of Science:
- Cardiovascular Research
- Vascular Biology
- Interventional Cardiology
Background:
- Restenosis is a significant limitation of endovascular treatments for atherosclerotic diseases.
- Despite advances, restenosis remains a clinical challenge, impacting long-term patency rates.
- Late lumen loss after angioplasty necessitates understanding its underlying pathophysiology.
Purpose of the Study:
- To review recent findings on vascular inflammation and restenosis following percutaneous angioplasty.
- To highlight the role of inflammatory parameters as predictors of restenosis risk.
- To focus on the peripheral vascular area for restenosis risk assessment.
Main Methods:
- Literature review of recent research on inflammation and restenosis.
- Analysis of studies investigating inflammatory markers and their correlation with restenosis.
- Focus on studies pertaining to peripheral arterial interventions.
Main Results:
- Vascular inflammation is a key factor in the restenotic process after angioplasty and stenting.
- Several inflammatory markers have been identified as potential predictors of restenosis.
- Inflammatory parameters show promise in assessing restenosis risk, particularly in peripheral vessels.
Conclusions:
- Understanding the pathophysiology of restenosis, particularly vascular inflammation, is crucial for improving patient outcomes.
- Inflammatory markers can serve as valuable tools for predicting restenosis risk after endovascular procedures.
- Further research into inflammatory markers in the peripheral vasculature may lead to better management strategies for restenosis.
Abstract:
Restenosis after endovascular treatment of atherosclerotic lesions in the peripheral, cerebrovascular, and coronary circulation is the major drawback of this minimally invasive technique. Although certain advances have been made during recent years to improve patency rates after percutaneous angioplasty, restenosis remains a challenging clinical problem. Understanding factors that contribute to the pathophysiology of late lumen loss is an effective strategy to improving patients' postangioplasty outcome. Vascular inflammation after balloon angioplasty or stent implantation has been identified as a cornerstone of the restenotic process, and several markers of inflammation have been referred to as potential predictors of outcome. This article reviews recent findings on the issue of inflammation and restenosis after percutaneous angioplasty with special attention given to the role of inflammatory parameters as markers for the restenosis risk in the peripheral vessel area.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Vascular Spasm
Peripheral Artery Disease I: Introduction
Mechanism of Angiogenesis
Acute Inflammation III: Local and Systemic Effects
Inflammation
